The WISE workshop reviewed gender differences in the clinical manifestations, detection, and treatment of ischemic heart disease, highlighting research needs in understanding pathophysiology in women.
Answers are grounded in this paper and cite their sources.
Does not support changes to IHD care in women; leaves open key questions on sex-specific pathophysiology and detection.
T he WISE workshop was convened to review results from the Women's Ischemic Syndrome Evaluation (WISE) study and other studies of ischemic heart disease to examine the nature and scope of gender differences in both chronic and acute cardiac ischemia, in terms of clinical manifestations, detection, and treatment.This section addresses research needs in understanding the pathophysiology of chronic myocardial ischemic syndromes in women and mechanisms for gender differences.
No takes yet. Share an insight, caveat, or question.
Redberg et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: